Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology  |  Oncology  |  Family Medicine  |  Urology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Bladder Cancer Clinical Trials

A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (469) clinical trials

A research study is evaluating an investigational blood sample diagnostic test combined with liver ultrasounds, compared to ultrasounds alone, for the detection of liver cancer in people with liver cirrhosis.  

Phase N/A

People with bladder cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

People with urothelial cancer are asked to participate in a research study being conducted by White Plains Hospital.  

Phase N/A

Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and ...

Phase

- This is the first study where BAY1163877 is given to humans. Impact of the study is to evaluate if patients with advanced solid cancers show advanced clinical benefit under the treatment with the pan FGFR inhibitor. Patients (all comers) will receive the study drug treatment in a dose-escalation scheme ...

Phase

People with bladder cancer are asked to participate in a research study being conducted by Northwell Health.  

Phase N/A

People with bladder cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

Phase N/A

The purpose of this study is to evaluate the safety and efficacy of pemigatinib plus pembrolizumab or pemigatinib alone versus the standard of care for participants with metastatic or unresectable urothelial carcinoma who are not eligible to receive cisplatin, are harboring FGFR3 mutation or rearrangement, and who have not received ...

Phase

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00980460?term=AHEP0731&rank=1

Phase N/A

To evaluate the pharmacokinetics and safety of copanlisib in subjects with impaired hepatic or renal function in comparison to healthy subjects

Phase